# SGI Venture Capital

> SGI Venture Capital is a VC fund in Seoul backing Medical and Software. See 40 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 40
- Last investment: Jun 2026
- Lead investor: 10%
- Last updated: Aug 2026
- Website: http://www.sgivc.com

SGI Venture Capital is a VC fund in Seoul focused on Medical and Software. Founded in 2007, SGI (Samho Green Investment) is the first and only venture capital firm in Korea focused on the green growth sector, including renewable energy, green and agricultural technologies. We engage in venture capital and private equity investments for mergers & acquisitions and buyouts, and conduct business as well as engineeringconsulting for our portfolio and client companies.Our investment focus areas are green technology (greentech) commercialization, green infrastructure and agricultural technologies (agritech), as well as early-stage project development. We have an experienced team of in-house greentech specialists and an extensive domestic and international greentech network, which assists us in deal sourcing, value creation and exit management.

## Contacts

5 contacts available for SGI Venture Capital. Shizune tracks 1 team members at SGI Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sgi-venture-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $971k–$6M |
| Series A | $1.5M–$17M |
| Series B | $1.1M–$47M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 8 | 20% |
| Software | 4 | 10% |
| Health Care | 4 | 10% |
| Biotechnology | 4 | 10% |
| Therapeutics | 3 | 8% |

59 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 15 | 38% |
| Series B | 6 | 15% |
| Seed | 4 | 10% |
| Funding Round | 3 | 8% |
| Series C | 2 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 25 | 63% |
| Singapore | 1 | 3% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jiyoung Tim Kang | Executive Managing Director | 2 | https://shizune.co/investors/profile/jiyoung-tim-kang |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| FNCT Biotech | FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option. | $14M | Series B | Jun 16, 2026 |  |
| Solivis | Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time. | $13.7M | Series C | Jun 04, 2026 |  |
| Unastella | Unastella is an aerospace company developing human spaceflight technologies, including launch vehicles and suborbital tourism systems. The company focuses on advancing reusable rocket technology and future space travel infrastructure for civilian space exploration missions. Unastella aims to support the growth of private human spaceflight andnext-generation aerospace innovation. | $22.2M | Series B | Jun 01, 2026 |  |
| PineTree Therapeutics | PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $47M | Series B | Oct 28, 2025 |  |
| Bem Robotics | Bem Robotics is developer of indoor industrial robotics technology designed to improve automated material handling and operational control | $3.6M | Series A | Aug 18, 2025 |  |
| Dime Bio | Dime Bio is a drug development company for novel dementia treatments. | $8.2M | Series A | Mar 26, 2025 |  |
| Airbility | Airability is a developer for potential airline mobility solutions. | $1.7M | Series A | Jan 22, 2025 |  |
| Airbility | Airability is a developer for potential airline mobility solutions. | $1.7M | Seed | Jan 22, 2025 |  |
| Soomvi | Soomvi is an industrial drone market company that provides marine lifesaving system services. | $5.5M | Venture - Series Unknown | Dec 23, 2024 |  |
| Lookinsight | Lookinsight is a solution to solve the problems of the pharmaceutical distribution industry. | $1M | Seed | Dec 01, 2024 |  |

10 of 40 investments shown.

## Co-investors
- [DSC Investment](https://shizune.co/investors/profile/dsc-investment) — VC Fund, 5 deals together
- [Hana Ventures](https://shizune.co/investors/profile/hana-ventures) — VC Fund, 5 deals together
- [KDB Capital](https://shizune.co/investors/profile/kdb-capital) — VC Fund, 5 deals together
- [SL Investment](https://shizune.co/investors/profile/sl-investment) — VC Fund, 4 deals together
- [Bass Investment](https://shizune.co/investors/profile/bass-investment) — VC Fund, 3 deals together
- [BNK Venture Capital](https://shizune.co/investors/profile/bnk-venture-capital-c3fd) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Transportation Investors in South Korea](https://shizune.co/investors/transportation-investors-south-korea)
- [Transportation VC Funds in South Korea](https://shizune.co/investors/transportation-vc-funds-south-korea)
- [Medical VC Funds in South Korea](https://shizune.co/investors/medical-vc-funds-south-korea)
- [All Investors in South Korea](https://shizune.co/investors/investors-south-korea)
- [All VC Funds in South Korea](https://shizune.co/investors/vc-funds-south-korea)
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)

## FAQ

### What does SGI Venture Capital invest in?

SGI Venture Capital invests primarily in Medical, Software and Health Care startups, most often at Series A and Series B stage. Most of the 40 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is SGI Venture Capital's check size?

SGI Venture Capital typically joins rounds of $971k–$6M at Seed, $1.5M–$17M at Series A and $1.1M–$47M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SGI Venture Capital participates in.

### How do I contact SGI Venture Capital?

Public channels for SGI Venture Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SGI Venture Capital?

The team at SGI Venture Capital includes Jiyoung Tim Kang (Executive Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co